These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 31259647

  • 1. The Efficacy of 2% Topical Rebamipide on Conjunctival Squamous Metaplasia and Goblet Cell Density in Dry Eye Disease.
    Simsek C, Dogru M, Shinzawa M, Den S, Kojima T, Iseda H, Suzuki M, Shibasaki Y, Yoshida N, Shimazaki J.
    J Ocul Pharmacol Ther; 2019; 35(6):350-358. PubMed ID: 31259647
    [Abstract] [Full Text] [Related]

  • 2. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
    Kinoshita S, Oshiden K, Awamura S, Suzuki H, Nakamichi N, Yokoi N, Rebamipide Ophthalmic Suspension Phase 3 Study Group.
    Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326
    [Abstract] [Full Text] [Related]

  • 3. The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (sod1) knockout mice.
    Ohguchi T, Kojima T, Ibrahim OM, Nagata T, Shimizu T, Shirasawa T, Kawakita T, Satake Y, Tsubota K, Shimazaki J, Ishida S.
    Invest Ophthalmol Vis Sci; 2013 Nov 21; 54(12):7793-802. PubMed ID: 24168989
    [Abstract] [Full Text] [Related]

  • 4. Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
    Kinoshita S, Awamura S, Oshiden K, Nakamichi N, Suzuki H, Yokoi N, Rebamipide Ophthalmic Suspension Phase II Study Group.
    Ophthalmology; 2012 Dec 21; 119(12):2471-8. PubMed ID: 23009892
    [Abstract] [Full Text] [Related]

  • 5. The Role of 2% Rebamipide Eye Drops Related to Conjunctival Differentiation in Superoxide Dismutase-1 (Sod1) Knockout Mice.
    Kojima T, Simsek C, Igarashi A, Aoki K, Higa K, Shimizu T, Dogru M, Tsubota K, Shimazaki J.
    Invest Ophthalmol Vis Sci; 2018 Mar 01; 59(3):1675-1681. PubMed ID: 29625494
    [Abstract] [Full Text] [Related]

  • 6. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
    Wang Y, Ogawa Y, Dogru M, Kawai M, Tatematsu Y, Uchino M, Okada N, Igarashi A, Kujira A, Fujishima H, Okamoto S, Shimazaki J, Tsubota K.
    Bone Marrow Transplant; 2008 Feb 01; 41(3):293-302. PubMed ID: 17982500
    [Abstract] [Full Text] [Related]

  • 7. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
    Demiryay E, Yaylali V, Cetin EN, Yildirim C.
    Eye Contact Lens; 2011 Sep 01; 37(5):312-5. PubMed ID: 21792057
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness and relevant factors of 2% rebamipide ophthalmic suspension treatment in dry eye.
    Ueda K, Matsumiya W, Otsuka K, Maeda Y, Nagai T, Nakamura M.
    BMC Ophthalmol; 2015 Jun 06; 15():58. PubMed ID: 26048396
    [Abstract] [Full Text] [Related]

  • 9. Immune profile of squamous metaplasia development in autoimmune regulator-deficient dry eye.
    Chen YT, Li S, Nikulina K, Porco T, Gallup M, McNamara N.
    Mol Vis; 2009 Jun 06; 15():563-76. PubMed ID: 19365590
    [Abstract] [Full Text] [Related]

  • 10. Secreted Mucins on the Ocular Surface.
    Hori Y.
    Invest Ophthalmol Vis Sci; 2018 Nov 01; 59(14):DES151-DES156. PubMed ID: 30481820
    [Abstract] [Full Text] [Related]

  • 11. Impression cytology on conjunctiva and cornea in dry eye patients establishes a correlation between squamous metaplasia and dry eye clinical severity.
    Murube J, Rivas L.
    Eur J Ophthalmol; 2003 Mar 01; 13(2):115-27. PubMed ID: 12696629
    [Abstract] [Full Text] [Related]

  • 12. The conjunctival epithelium in dry eye subtypes: effect of preserved and non-preserved topical treatments.
    Albietz JM, Bruce AS.
    Curr Eye Res; 2001 Jan 01; 22(1):8-18. PubMed ID: 11402374
    [Abstract] [Full Text] [Related]

  • 13. Graft Versus Host Disease-Associated Dry Eye: Role of Ocular Surface Mucins and the Effect of Rebamipide, a Mucin Secretagogue.
    Shamloo K, Barbarino A, Alfuraih S, Sharma A.
    Invest Ophthalmol Vis Sci; 2019 Nov 01; 60(14):4511-4519. PubMed ID: 31675422
    [Abstract] [Full Text] [Related]

  • 14. Improvements in Signs and Symptoms of Dry Eye after Instillation of 2% Rebamipide.
    Igarashi T, Fujita M, Yamada Y, Kobayashi M, Fujimoto C, Takahashi H, Igarashi T, Nakano Y, Suzuki H, Takahashi H.
    J Nippon Med Sch; 2015 Nov 01; 82(5):229-36. PubMed ID: 26568389
    [Abstract] [Full Text] [Related]

  • 15. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
    Pflugfelder SC, De Paiva CS, Villarreal AL, Stern ME.
    Cornea; 2008 Jan 01; 27(1):64-9. PubMed ID: 18245969
    [Abstract] [Full Text] [Related]

  • 16. A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye.
    Kinoshita S, Awamura S, Nakamichi N, Suzuki H, Oshiden K, Yokoi N, Rebamipide Ophthalmic Suspension Long-term Study Group.
    Am J Ophthalmol; 2014 Mar 01; 157(3):576-83.e1. PubMed ID: 24246575
    [Abstract] [Full Text] [Related]

  • 17. Tear function and ocular surface changes with topical mitomycin (MMC) treatment for primary corneal intraepithelial neoplasia.
    Dogru M, Erturk H, Shimazaki J, Tsubota K, Gul M.
    Cornea; 2003 Oct 01; 22(7):627-39. PubMed ID: 14508259
    [Abstract] [Full Text] [Related]

  • 18. Conjunctival Goblet Cell Density Following Cataract Surgery With Diclofenac Versus Diclofenac and Rebamipide: A Randomized Trial.
    Kato K, Miyake K, Kondo N, Asano S, Takeda J, Takahashi A, Takashima Y, Kondo M.
    Am J Ophthalmol; 2017 Sep 01; 181():26-36. PubMed ID: 28669778
    [Abstract] [Full Text] [Related]

  • 19. The application of autologous serum eye drops in severe dry eye patients; subjective and objective parameters before and after treatment.
    Jirsova K, Brejchova K, Krabcova I, Filipec M, Al Fakih A, Palos M, Vesela V.
    Curr Eye Res; 2014 Jan 01; 39(1):21-30. PubMed ID: 24074049
    [Abstract] [Full Text] [Related]

  • 20. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E, Asfuroğlu E.
    Cornea; 2010 Feb 01; 29(2):133-40. PubMed ID: 19966564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.